Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
16,037 | Dovepress* | 14,849+ | 1,615 | 16,464 | |
PubMed Central* | 1,188 | 326 | 1,514 | ||
Totals | 16,037 | 1,941 | 17,978 | ||
*Since 3 October 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar